NZZ Equity Biotech Day - Speakers 2012

Keynote Speaker
Dr. Sophie Kornowski-Bonnet
Dr. Sophie Kornowski-Bonnet
Head of Roche Partnering, F. Hoffmann-La Roche Ltd.
Speakers
Christian Brühlmann
Christian Brühlmann
CFO, ProteoMediX AG
Dr. Nina Geib
Dr. Nina Geib
CEO, Virometix AG
Neil Goldsmith
Neil Goldsmith
CEO, Evolva Holding SA
Daniel Leutenegger
Daniel Leutenegger
CEO, Stemergie Biotechnology SA
Dr. Villoo Morawala Patell
Dr. Villoo Morawala Patell
Founder, Chairperson and Managing Director, Avesthagen Ltd.
Dr. Riccardo Nisato
Dr. Riccardo Nisato
Director Manufacturing & Clinical Business Development, Stemedica International SA
Muralidhar Pothupalem
Muralidhar Pothupalem
Senior Director, Dr. Reddy's Laboratories Ltd.
Colin Sanctuary
Colin Sanctuary
CEO, QGel Sa
Dr. Chris Tanner
Dr. Chris Tanner
CFO, Cosmo Pharmaceuticals S.p.A.
Dr. Michael Buschle
Dr. Michael Buschle
CSO, Glenmark Pharmaceuticals SA
Dr. Christian Zahnd
Dr. Christian Zahnd
CEO, Molecular Partners AG
Speech: A review of the recent deal-making and licensing at pharma and biotech
Michael Johnson
Michael Johnson
Practice Leader, Deloitte Recap
Speech: Is any money good money? – choosing the right partnership model with investors
Francis Marsland
Francis Marsland
VP European Development and Site Leader, Biogen Idec International GmbH
Speech: Bioinformatics in Switzerland - an unequalled concentration of expertise and resources for biomedical research
Prof. Dr. Ron D. Appel
Prof. Dr. Ron D. Appel
Executive Director, Swiss Institute of Bioinformatics (SIB)
Presentation of the Swiss Biotech Report 2012 (followed by a moderated Q&A)
Jürg Zürcher
Jürg Zürcher
Partner, Biotechnology Leader EMEIA, Ernst & Young AG
Prof. Dr. Oreste Ghisalba
Prof. Dr. Oreste Ghisalba
Head, CTI Biotech Commission for Technololgy and Innovation (CTI)
Prof. Dr. Heinz Müller
Prof. Dr. Heinz Müller
Patent Expert, Swiss Federal Institute of Intellectual Property
Panel discussion: Biotech in Switzerland and India - a comparison
Balaji Bondili
Balaji Bondili
Senior Manager Life Sciences and Healthcare consulting, Deloitte India
Dr. Reinhard Glück
Dr. Reinhard Glück
President, Swiss Biotech Association
Dr. Villoo Morawala Patell
Dr. Villoo Morawala Patell
Founder, Chairperson & Managing Director, Avesthagen Ltd.
Dr. P. M. Murali
Dr. P. M. Murali
CEO, Evolva India
Panel discussion: Early and late stage biotech financing: Is the traditional model dead?
Dr. Stefan Kohler
Dr. Stefan Kohler
Partner, VISCHER AG
Dr. Matthias Staehelin
Dr. Matthias Staehelin
Partner, VISCHER AG
Harry Welten
Harry Welten
CFO, Cytos Biotechnology AG
Moderators
Domenico P. Alexakis
Domenico P. Alexakis
CEO, Swiss Biotech Association
Birgit Voigt
Birgit Voigt
NZZ am Sonntag
Björn Zern
Björn Zern
Head of Conferences & Services, Neue Zürcher Zeitung
Dr. Holger Bengs
Dr. Holger Bengs
CEO & Managing Partner, BCNP Consultants GmbH